Skip to main content

Rh immunoglobulin (Rhogam) for Rh negative pregnant women at risk of fetal blood exposure.

CBE ID
0652
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description

Percent of Rh negative pregnant women at risk of fetal blood exposure who receive Rhogam the ED.

    Measure Specs
      General Information
      1.7 Measure Type
      1.3 Electronic Clinical Quality Measure (eCQM)
      1.9 Care Setting
      1.14 Numerator

      Number of appropriate patients who receive Rhogam in the ED.

      1.15 Denominator

      All women, confirmed pregnant, who are at significant risk of fetal blood exposure, including:
      1. those diagnosed with an ectopic pregnancy
      2. those in the second or third trimester:
      a: with a threatened abortion (threatened, partial, complete, or spontaneous)
      b. those who report or are found to have significant vaginal bleeding (not just spotting)
      c. those who have sustained blunt abdominal trauma
      3. those who undergo an invasive obstetric procedure in the ED (genetic amniocentesis; chorion villus sampling; fetal blood sampling, D&C).

      Exclusions

      1. Patient refusal
      2. Patients who have received appropriate Rh immunoglobulin previously
      3. OB/GYN consultation documenting Rh immunoglobulin not recommended

      Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed National Voluntary Consensus Standards for Ambulatory Care: Additional Outpatient Measures 2010
      Initial Endorsement
      Last Updated
      Removal Date
      Steward Organization
      American College of Emergency Physicians
      Steward POC email
      sjones@acep.org
      Steward Organization Copyright

      None

                Public Comments